GrayMatters Health Wins Edison Gold Award for its Innovative PTSD Treatment [Yahoo! Finance]
THERAPEUTIC SLTNS INTL (TSOI)
NASDAQ:AMEX Investor Relations:
ir.renesolapower.com
Company Research
Source: Yahoo! Finance
HAIFA , Israel and NEW YORK April 22, 2024 /PRNewswire/ -- GrayMatters Health (GMH) , developer of digital self-neuromodulation treatments for mental health care, today announced its flagship FDA-cleared device Prism for PTSD has been named a Gold winner of the 2024 Edison Awards™. An estimated 13 million Americans have post-traumatic stress disorder (PTSD) following assault, abuse, combat, illness, accidents, or natural disasters. While standard-of-care treatments have proven effective for many, 30% of patients do not achieve symptom relief. Prism for PTSD, now available in select US clinics, is the first prescribed self-neuromodulation device to receive FDA clearance to treat PTSD. Over an eight-week regimen in the clinic, patients engage in a non-trauma-based treatment where they learn to gain control of PTSD symptoms. "Prism for PTSD gathers years of neuroscience research into an evidence-based treatment that helps improve clinical outcomes," said Oded Kraft , CEO and Co-Fo
Show less
Read more
Impact Snapshot
Event Time:
TSOI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TSOI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TSOI alerts
High impacting THERAPEUTIC SLTNS INTL news events
Weekly update
A roundup of the hottest topics
TSOI
News
- Essential Pharma and AcedrA Biopharmaceuticals sign Distribution Agreement to commercialize essential medicines in the Middle East and North Africa region [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Essential Pharma and AcedrA Biopharmaceuticals sign Distribution Agreement to commercialize essential medicines in the Middle East and North Africa region [Yahoo! Finance]Yahoo! Finance
- Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients [Yahoo! Finance]Yahoo! Finance
- Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 PatientsBusiness Wire
- Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product [Yahoo! Finance]Yahoo! Finance
TSOI
Sec Filings
- 4/19/24 - Form 4
- 4/19/24 - Form 4
- 4/17/24 - Form 10-K
- TSOI's page on the SEC website